Skip to main content
. Author manuscript; available in PMC: 2017 Aug 21.
Published in final edited form as: J Am Coll Cardiol. 2017 Feb 21;69(7):841–858. doi: 10.1016/j.jacc.2016.11.069

FIGURE 8. Effect of CPAP Treatment on CV Risk.

FIGURE 8

The figure shows the incidence risk for the primary composite endpoints in 3 RCTs (49,63,64) in the CPAP compared with the control group (hazard ratio or incidence density ratio, 95% CI) in the intention-to-treat analysis and in the adherence analysis (patients with CPAP adherence ≥4 h/day). *In the McEvoy study (49), the significant CV improvement in patients who used CPAP ≥4 h/day was only achieved in the risk of a cerebrovascular event, but not in the primary composite outcome. CV = cardiovascular; other abbreviations as in Figure 6.